Tibet Eastmoney CSI SH-HK-SZ Brand Name Drug Industry ETF (SHE:159622)

China · Delayed Price · Currency is CNY

1.221

+0.002 (0.16%)

At close: Sep 23, 2026

Assets	n/a
Expense Ratio	n/a
PE Ratio	27.87
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	-3.41%

Volume	46,749,300
Open	1.219
Previous Close	1.219
Day's Range	1.215 - 1.233
52-Week Low	0.884
52-Week High	1.297
Beta	0.31
Holdings	n/a
Inception Date	Apr 21, 2023

About 159622

159622.SZ was created on 2023-04-21 by Dongcai. The fund's investment portfolio concentrates primarily on health care equity. Tightly track the target index, pursue the minimization of tracking deviation and tracking error.

Asset Class Equity

Category Health Care

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 159622

Provider Dongcai

Index Tracked CSI Shanghai-Hong Kong-Shenzhen Innovative Drug Industry Index - CNY - Benchmark TR Gross

Performance

159622 had a total return of -3.41% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.07%.